Global Antibody Drug Conjugates Market Insights, Forecast

Antibody Drug Conjugates are highly effective biopharmaceutical medications designed as a targeted therapy for cancer treatment. The preparation process of ADC’s involves great difficulty, inspite of these hurdles recently approved ADC’s have proved their worth for treatment of cancer. Thus, there is a strong pipeline of ADC’s that promises revolutionary changes in area of targeted therapy for cancer treatment. This market is driven by elements such as continuous improvement in the clinical data and technological advancements in the field of drug development shelling out innovative drugs into the market. The global Antibody Drug Conjugates market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Antibody Drug Conjugates market based on company, product type, end user and key regions. This report studies the global market size of Antibody Drug Conjugates in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Antibody Drug Conjugates in these regions. This research report categorizes the global Antibody Drug Conjugates market by top players/brands, region, type and end user. This report also studies the global Antibody Drug Conjugates market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors. The following manufacturers are covered in this report, with sales, revenue, market share for each company: F. Hoffman-La Roche Novartis AG Takeda Pharmaceutical Pfizer Seattle Genetics Genentech Immunogen Progenics Pharmaceuticals Bayer Healthcare Pharmaceuticals Market size by Product Adcetris Kadcyla Market size by End User Breast Cancer Lymphoma Market size by Region North America United States Canada Mexico Asia-Pacific China India Japan South Korea Australia Indonesia Singapore Malaysia Philippines Thailand Vietnam Europe Germany France UK Italy Spain Russia Central & South America Brazil Rest of Central & South America Middle East & Africa GCC Countries Turkey Egypt South Africa The study objectives of this report are: To study and analyze the global Antibody Drug Conjugates market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025. To understand the structure of Antibody Drug Conjugates market by identifying its various subsegments. To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks). Focuses on the key global Antibody Drug Conjugates companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development. To project the value and sales volume of Antibody Drug Conjugates submarkets, with respect to key regions. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market. In this study, the years considered to estimate the market size of Antibody Drug Conjugates are as follows: History Year: 2014-2018 Base Year: 2018 Estimated Year: 2019 Forecast Year 2019 to 2025 This report includes the estimation of market size for value (million US$) and volume (MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Antibody Drug Conjugates market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources. For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Get sample copy of the report:

https://www.marketdensity.com/contact?ref=Sample&reportid=119233

Table of Contents:

Table of Contents

1 Study Coverage
1.1 Antibody Drug Conjugates Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Antibody Drug Conjugates Market Size Growth Rate by Product
1.4.2 Adcetris
1.4.3 Kadcyla
1.5 Market by End User
1.5.1 Global Antibody Drug Conjugates Market Size Growth Rate by End User
1.5.2 Breast Cancer
1.5.3 Lymphoma
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Antibody Drug Conjugates Market Size
2.1.1 Global Antibody Drug Conjugates Revenue 2014-2025
2.1.2 Global Antibody Drug Conjugates Sales 2014-2025
2.2 Antibody Drug Conjugates Growth Rate by Regions
2.2.1 Global Antibody Drug Conjugates Sales by Regions
2.2.2 Global Antibody Drug Conjugates Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Antibody Drug Conjugates Sales by Manufacturers
3.1.1 Antibody Drug Conjugates Sales by Manufacturers
3.1.2 Antibody Drug Conjugates Sales Market Share by Manufacturers
3.1.3 Global Antibody Drug Conjugates Market Concentration Ratio (CR5 and HHI)
3.2 Antibody Drug Conjugates Revenue by Manufacturers
3.2.1 Antibody Drug Conjugates Revenue by Manufacturers (2014-2019)
3.2.2 Antibody Drug Conjugates Revenue Share by Manufacturers (2014-2019)
3.3 Antibody Drug Conjugates Price by Manufacturers
3.4 Antibody Drug Conjugates Manufacturing Base Distribution, Product Types
3.4.1 Antibody Drug Conjugates Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Antibody Drug Conjugates Product Type
3.4.3 Date of International Manufacturers Enter into Antibody Drug Conjugates Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product
4.1 Global Antibody Drug Conjugates Sales by Product
4.2 Global Antibody Drug Conjugates Revenue by Product
4.3 Antibody Drug Conjugates Price by Product

5 Breakdown Data by End User
5.1 Overview
5.2 Global Antibody Drug Conjugates Breakdown Data by End User

6 North America
6.1 North America Antibody Drug Conjugates by Countries
6.1.1 North America Antibody Drug Conjugates Sales by Countries
6.1.2 North America Antibody Drug Conjugates Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Antibody Drug Conjugates by Product
6.3 North America Antibody Drug Conjugates by End User

7 Europe
7.1 Europe Antibody Drug Conjugates by Countries
7.1.1 Europe Antibody Drug Conjugates Sales by Countries
7.1.2 Europe Antibody Drug Conjugates Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Antibody Drug Conjugates by Product
7.3 Europe Antibody Drug Conjugates by End User

8 Asia Pacific
8.1 Asia Pacific Antibody Drug Conjugates by Countries
8.1.1 Asia Pacific Antibody Drug Conjugates Sales by Countries
8.1.2 Asia Pacific Antibody Drug Conjugates Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Antibody Drug Conjugates by Product
8.3 Asia Pacific Antibody Drug Conjugates by End User

9 Central & South America
9.1 Central & South America Antibody Drug Conjugates by Countries
9.1.1 Central & South America Antibody Drug Conjugates Sales by Countries
9.1.2 Central & South America Antibody Drug Conjugates Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Antibody Drug Conjugates by Product
9.3 Central & South America Antibody Drug Conjugates by End User

10 Middle East and Africa
10.1 Middle East and Africa Antibody Drug Conjugates by Countries
10.1.1 Middle East and Africa Antibody Drug Conjugates Sales by Countries
10.1.2 Middle East and Africa Antibody Drug Conjugates Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Antibody Drug Conjugates by Product
10.3 Middle East and Africa Antibody Drug Conjugates by End User

11 Company Profiles
11.1 F. Hoffman-La Roche
11.1.1 F. Hoffman-La Roche Company Details
11.1.2 Company Business Overview
11.1.3 F. Hoffman-La Roche Antibody Drug Conjugates Sales, Revenue and Gross Margin (2014-2019)
11.1.4 F. Hoffman-La Roche Antibody Drug Conjugates Products Offered
11.1.5 F. Hoffman-La Roche Recent Development
11.2 Novartis AG
11.2.1 Novartis AG Company Details
11.2.2 Company Business Overview
11.2.3 Novartis AG Antibody Drug Conjugates Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Novartis AG Antibody Drug Conjugates Products Offered
11.2.5 Novartis AG Recent Development
11.3 Takeda Pharmaceutical
11.3.1 Takeda Pharmaceutical Company Details
11.3.2 Company Business Overview
11.3.Takeda Pharmaceutical Antibody Drug Conjugates Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Takeda Pharmaceutical Antibody Drug Conjugates Products Offered
11.3.5 Takeda Pharmaceutical Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Details
11.4.2 Company Business Overview
11.4.3 Pfizer Antibody Drug Conjugates Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Pfizer Antibody Drug Conjugates Products Offered
11.4.5 Pfizer Recent Development
11.5 Seattle Genetics
11.5.1 Seattle Genetics Company Details
11.5.2 Company Business Overview
11.5.3 Seattle Genetics Antibody Drug Conjugates Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Seattle Genetics Antibody Drug Conjugates Products Offered
11.5.5 Seattle Genetics Recent Development
11.6 Genentech
11.6.1 Genentech Company Details
11.6.2 Company Business Overview
11.6.3 Genentech Antibody Drug Conjugates Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Genentech Antibody Drug Conjugates Products Offered
11.6.5 Genentech Recent Development
11.7 Immunogen
11.7.1 Immunogen Company Details
11.7.2 Company Business Overview
11.7.3 Immunogen Antibody Drug Conjugates Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Immunogen Antibody Drug Conjugates Products Offered
11.7.5 Immunogen Recent Development
11.8 Progenics Pharmaceuticals
11.8.1 Progenics Pharmaceuticals Company Details
11.8.2 Company Business Overview
11.8.3 Progenics Pharmaceuticals Antibody Drug Conjugates Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Progenics Pharmaceuticals Antibody Drug Conjugates Products Offered
11.8.5 Progenics Pharmaceuticals Recent Development
11.9 Bayer Healthcare Pharmaceuticals
11.9.1 Bayer Healthcare Pharmaceuticals Company Details
11.9.2 Company Business Overview
11.9.3 Bayer Healthcare Pharmaceuticals Antibody Drug Conjugates Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Bayer Healthcare Pharmaceuticals Antibody Drug Conjugates Products Offered
11.9.5 Bayer Healthcare Pharmaceuticals Recent Development

12 Future Forecast
12.1 Antibody Drug Conjugates Market Forecast by Regions
12.1.1 Global Antibody Drug Conjugates Sales Forecast by Regions 2019-2025
12.1.2 Global Antibody Drug Conjugates Revenue Forecast by Regions 2019-2025
12.2 Antibody Drug Conjugates Market Forecast by Product
12.2.1 Global Antibody Drug Conjugates Sales Forecast by Product 2019-2025
12.2.2 Global Antibody Drug Conjugates Revenue Forecast by Product 2019-2025
12.3 Antibody Drug Conjugates Market Forecast by End User
12.4 North America Antibody Drug Conjugates Forecast
12.5 Europe Antibody Drug Conjugates Forecast
12.6 Asia Pacific Antibody Drug Conjugates Forecast
12.7 Central & South America Antibody Drug Conjugates Forecast
12.8 Middle East and Africa Antibody Drug Conjugates Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Antibody Drug Conjugates Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Browse this report online:

https://www.marketdensity.com/global-antibody-drug-conjugates-market-insights-forecast

About Market Density:

Market Density is your one stop market research and industry analysis reports' library providing business data and intelligence information on thousands of micro markets with global as well as regional coverage.
Market Density offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.
Market Density understands how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available.
Contact Us:

Email: sales@marketdensity.com

Website: www.marketdensity.com

Phone: +1 669 264 1656

4340 Stevens Creek Blvd,, Suite # 172,, San Jose, CA 95129

This release was published on openPR.